FMP
Protagenic Therapeutics, Inc.
PTIX
NASDAQ
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
0.3 USD
0.0412 (13.73%)
PTIX Financial Statements
Year
2024
2023
2022
2021
Current Assets
1.88M
4.2M
8.04M
11.06M
Cash & Short Term Investments
1.84M
4.06M
7.98M
10.37M
Cash And Cash Equivalents
1.84M
1.29M
215.19k
541.17k
Short Term Investments
0
2.77M
7.76M
9.83M
Net Receivables
0
0
0
0
Inventory
0
0
0
0
Other Current Assets
44.4k
0
0
0
Non-Current Assets
73.05k
123.33k
1.77k
0
Property, Plant & Equipment
0
123.33k
1.77k
0
Goodwill And Intangible Assets
0
0
0
0
Goodwill
0
0
0
0
Intangible Assets
0
0
0
0
Long Term Investments
0
0
0
0
Tax Assets
0
0
0
0
Other Non-Current Assets
73.05k
0
0
0
Other Assets
0
0
0
0
Total Assets
1.96M
4.32M
8.04M
11.06M
-
-
-
-
Current Liabilities
942.76k
655.25k
1.12M
799.53k
Accounts Payable
102.96k
113.8k
155.49k
278.96k
Short Term Debt
0
0
344.23k
0
Tax Payables
0
0
0
0
Deferred Revenue
0
0
0
0
Other Current Liabilities
839.8k
0
0
0
Total Current Liabilities
942.76k
655.25k
1.12M
799.53k
Total Non-Current Liabilities
0
0
1.01M
318.43k
Long-Term Debt
0
0
0
318.43k
Deferred Revenue
0
0
0
0
Deferred Taxes Liabilities
0
0
0
0
Other Non Current liabilities
0
0
0
0
Total Liabilities
942.76k
655.25k
1.12M
1.12M
Other Liabilities
0
0
-1.01M
0
Stockholders Equity
1.01M
3.67M
6.92M
9.94M
Common Stock
725
444
434
1.72k
Retained Earnings
-36.3M
-30.78M
-25.78M
-22.22M
Accumulated Other Comprehensive Income/Loss
-129.85k
-113.55k
-676.91k
-248.35k
Other Shareholders Equity
37.45M
0
0
0
Total Liabilities and Stockholders Equity
1.96M
4.32M
8.04M
11.06M
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-30.78M
-25.78M
-22.22M
-17.7M
Net Income
-5.53M
-5M
-3.6M
-4.99M
Stock Repurchases
0
0
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-36.3M
-30.78M
-25.78M
-22.22M
Other Distributions
-5.53M
-5M
-3.56M
-4.52M
PPE Schedule
Year
2024
2023
2022
2021
Gross PPE
0
123.33k
1.77k
0
Annual Depreciation
0
28.22k
30
286
Capital Expenditure
0
-149.78k
-1.8k
0
Net PPE
0
244.89k
3.55k
-286
Intangible and Goodwill Schedule
Year
2024
2023
2022
2021
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
